AstraZeneca's diabetes drug Xigduo approved in Europe (Reuters, 22 January 2014)

22 Jan 2014


AstraZeneca reports the European approval of its fixed dose SGLT2 inhibitor and metformin combination Xigduo.

Full article


Share this story